Wal-Mart Stores (WMT) 78.18 $WMT Jim Cramer's 'Mad

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Wal-Mart Stores (WMT) 78.18 $WMT

Jim Cramer's 'Mad Money' Recap: What's Going on Here?
at The Street - 36 mins ago
The market is so confusing and Cramer is seeing some of his favorite stocks being sold off heavily.

Wal-Mart adding India outlets
at Investor's Business Daily - 52 mins ago
The world's No. 1 retailer will open 50 wholesale stores over the next 4-5 years, on top of 20 in India now. These "cash-and-carry stores" sell to retailers rather than consumers. Wal-Mart (WMT) also plans to launch an online operation for its...

Nordic American Tankers Plunges As Wal-Mart Looks to India for Growth
John Divine, The Motley Fool - Motley Fool - 55 mins ago
The Dow Jones Industrial Average broke a three-day losing streak today...in rather unremarkable fashion. 16 of its 30 components advanced, as the blue chip index tacked on all of 10 points, or 0.1%, to finish at 16,256. But lest we get spoiled, we...

Final Glance: Big-box Retail companies
AP - 1 hr 18 mins ago
NEW YORK (AP) — Shares of some top big-box retail companies were up at the close of trading:

After Yesterday's Rally of 1.13% Shares Could Potentially Pullback
Comtex SmarTrend(R) - 2 hrs 59 mins ago
Wal-Mart Stores (NYSE:WMT) traded in a range yesterday that spanned from a low of $76.80 to a high of $78.31. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $77.90 on volume of 7.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Watch for Wal-Mart Stores to Potentially Pullback After Gaining 1.13% Yesterday
Comtex SmarTrend(R) - 2 hrs 59 mins ago
Wal-Mart Stores (NYSE:WMT) traded in a range yesterday that spanned from a low of $76.80 to a high of $78.31. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $77.90 on volume of 7.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Big Lots, Target and Wal-Mart: Where Are They Placing Their Bets?
Celan Bryant, The Motley Fool - Motley Fool - Tue Apr 08, 3:21PM CDT
Big Lots has stores that are roughly the same size in square feet as Target , but that would be the end of the similarities between the two retailers. As Target opens 124 stores in Canada, marking the first year of international retail sales,...

Nike Sprints Higher as the Dow Dips Again
Dan Carroll, The Motley Fool - Motley Fool - Tue Apr 08, 1:39PM CDT
While stocks have bounced back from yesterday's big losses as the markets approach earnings season again, one index is heading down again. As of 2:35 p.m. EDT, the Dow Jones Industrial Average was just under breakeven, with blue-chip member stocks...

Midday Glance: Big-box Retail companies
AP - Tue Apr 08, 12:16PM CDT
NEW YORK (AP) — Shares of some top big-box retail companies are up at 1 p.m.:

Wal-Mart's Push Into India May Spread the Company Too Thin
Mark Reeth and Michael Finarelli, The Motley Fool - Motley Fool - Tue Apr 08, 12:14PM CDT
Much of the narrative around Wal-Mart in recent years has been its push into more international markets. Now, the company has announced that it will be opening 50 new stores across India. On today's Stock of the Day , Motley Fool analyst Michael...

Wal-Mart to expand wholesale outlets in India
By ANNE D'INNOCENZIO - AP - Tue Apr 08, 10:39AM CDT
NEW YORK (AP) — Wal-Mart Stores Inc. says it will open 50 more wholesale stores in India over the next four to five years, adding to the current total of 20 in the country.

Early Glance: Big-box Retail companies
AP - Tue Apr 08, 9:43AM CDT
NEW YORK (AP) — Shares of some top big-box retail companies are up at 10 a.m.:

Updated Research Report on Target - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 9:20AM CDT
Target's aggressive cost reduction strategy and anticipated turnaround of Canadian operations has neutralized the company's dismal quarterly performance.

Dividends Talk: What Procter & Gamble, TJX, and Wal-Mart Are Saying
Andrés Cardenal, The Motley Fool - Motley Fool - Tue Apr 08, 9:00AM CDT
Dividends can be enormously important, not only as a source of income for investors, but also because they confer valuable information about the health of a business and management´s expectations on the future. Let's look at recent dividend...

Product Launches, Corporate Name Changes, Financial Results Schedules, Stock Price Updates, and Filing Lawsuits - Analyst Notes on Amazon, Priceline, Netflix, eBay, and Walmart
PR Newswire - Tue Apr 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Amazon.com Inc. (NASDAQ: AMZN), priceline.com Incorporated (NASDAQ: PCLN), Netflix, Inc. (NASDAQ: NFLX), eBay Inc. (NASDAQ: EBAY), and Wal-Mart Stores Inc. (NYSE: WMT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register


Ow, Canada: US retailers get the cold shoulder
By ANNE D'INNOCENZIO and CHARMAINE NORONHA - AP - Mon Apr 07, 4:44PM CDT
For years, Canadians would cross the border to the U.S. to shop at Target. Exporting its cheap chic there seemed like a no-brainer.

Sozzi: Puppies! Kittens! Welcome to the Massive Pet Vitamin Boom!
at The Street - Mon Apr 07, 3:52PM CDT
Raise your hand if you post cute puppy and kitten photos on Twitter and Instagram. Well, pet selfies are about to explode as a result of the nicer weather, so be ready on the retweet and like buttons. Since you clearly love your pet, you should...

Should Supermarkets Be Worried About Amazon Dash?
Leo Sun, The Motley Fool - Motley Fool - Mon Apr 07, 12:17PM CDT
Amazon has been busy lately. Shortly after unveiling its new set-top box, the Fire TV , Amazon revealed Dash, a handheld device that allows customers to order groceries and household goods from home. Dash is a wand-like device...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 202

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 166

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 42

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 309

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 84

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 92

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading

Top 5 Most Recently Viewed Articles

Farmmi Receives Extension to Comply with NASDAQ Requirements

Updated Category News Views 64

Farmmi Secures NASDAQ Compliance Extension Farmmi, Inc. (NASDAQ: FAMI), a supplier of agricultural products, has been granted a 180-day extension by NASDAQ to meet its crucial minimum bid price requirement. This extension allows the company until the spring of 2025 to elevate its ordinary share bid price to at least $1.00 for at least ten consecutive business days. The...

Continue Reading
The Neurotechnology Surge: $57B Market by 2034

Updated Category News Views 16

Neurotechnology: The Rising Giant Elbows on the table, let's chew the fat about neurotechnology. The market, dizzyingly projected to soar past USD 57 billion by 2034, is on an explosive trajectory. Folk wiser than us predict an annual growth rate hanging around 14%. This ain't just whispers in coffee shops; it's cold, hard data from DelveInsight’s Market Insights...

Continue Reading
Reviva Pharmaceuticals' New Phase 3 Study for Schizophrenia Drug

Updated Category News Views 99

Reviva Pharmaceuticals' Regulatory Update Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) has recently provided an update regarding their journey with brilaroxazine, a novel drug aimed at treating schizophrenia. This news comes after a pre-New Drug Application meeting with the U.S. Food and Drug Administration (FDA). About Brilaroxazine Brilaroxazine is an innovative...

Continue Reading
Lowe's Reports Strong Earnings Amid Strategic Acquisitions

Updated Category News Views 117

Strong Q2 Earnings Surprise Lowe’s Companies Inc (NYSE: LOW) experienced better-than-expected second quarter earnings, bringing a burst of optimism for investors. The home improvement giant saw its stock increase by approximately 2% shortly after announcing its Q2 financial results. Having recorded solid performance through the quarter, Lowe’s exceeded analysts'...

Continue Reading
Invideo and Kling AI Unite for Game-Changing Visuals

Updated Category News Views 153

Invideo and Kling AI Collaborate to Redefine Video Editing Invideo has recently partnered with Kling AI to introduce an exciting tool known as VFX House. This innovative feature empowers creators with studio-level control for their video projects, offering enhanced capabilities for both marketing and editorial work. Unlocking New Possibilities with VFX House The...

Continue Reading